The distribution of FRAX®-based probabilities in women from Japan

Journal of Bone and Mineral Metabolism

Volumn 30, Issue 6, 2012, Pages 700-705

  Kanis, John A ^a   Johansson, Helena ^a   Odén, Anders ^a   McCloskey, Eugene V ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Assessment guidelines; Clinical risk factors; Fracture risk; Intervention threshold

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BONE DENSITY; COMPUTER PROGRAM; FEMALE; FEMUR NECK; FRAGILITY FRACTURE; HIGH RISK POPULATION; HUMAN; JAPAN; POSTMENOPAUSE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALGORITHMS; BONE DENSITY; FEMALE; FEMUR NECK; FRACTURES, BONE; HUMANS; JAPAN; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PREVALENCE; PROBABILITY; RISK ASSESSMENT; RISK FACTORS; SOFTWARE;

EID: 84875806165     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-012-0371-3     Document Type: Article

References (31)

1. Kanis JA on Behalf of the World Health Organization Scientific Group (2008) Assessment of osteoporosis at the primary health-care level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK. http://www.shef.ac.uk/FRAX
2. ®: assessment and intervention thresholds for the UK. Osteoporos Int 19:1395-1408 (erratum 2009 Osteoporos Int 20:499-502)
3. Fujiwara S, Nakamura T, Orimo H, Hosoi T, Gorai I, Odén A et al (2008) Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™). Osteoporos Int 19:429-448
4. ® and its applications to clinical practice. Bone (NY) 44:734-743
5. Kanis JA, Hans D, Cooper C, Task Force of the FRAX Initiative et al (2011) Interpretation and use of FRAX in clinical practice. Osteoporos Int 22:395-411
6. Compston J, Cooper A, Cooper C et al, on Behalf of the National Osteoporosis Guideline Group (NOGG) (2009) Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas 62:105-108
7. Grossman JM, Gordon R, Ranganath VK et al (2010) American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 62:1515-1526
8. Papaioannou A, Morin S, Cheung AM et al (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 182:1864-1873
9. Socialstyrelsen (2010) Nationella riktlinjer för rörelseorganens sjukdomar 2010 - stöd för styrning och ledning. Preliminär version. Artikelnr 2010-11-15. http://www.socialstyrelsen.se
10. Czerwinski E, Kanis JA, Trybulec B, Johansson H, Borowy P, Osieleniec J (2009) The incidence and risk of hip fracture in Poland. Osteoporos Int 20:1363-1368
11. Kanis JA, Burlet N, Cooper C et al, on Behalf of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19:399-428
12. Association Suisse contre l'Ostéoporose (2010) Ostéoporose: Recommandations 2010. ASCO http://www.svgo.ch/content/documents/SVGO- Empfehlungen2010-V19April2010.pdf
13. Dawson-Hughes B, National Osteoporosis Foundation Guide Committee (2008) A revised clinician's guide to the prevention and treatment of osteoporosis. J Clin Endocrinol Metab 93:2463-2465
14. ®. La Revue Médicale de Liège 64:612-619
15. ® assessment of osteoporotic fracture probability in Switzerland. Osteoporos Int 21:381-390
16. Committee of Japanese Guidelines for the Prevention and Treatment of Osteoporosis (2012) The Japanese guidelines for the prevention and treatment of osteoporosis, 2011 edn. Life Science Publishing, Tokyo (in Japanese)
17. Johansson H, Kanis JA, Odén A, Johnell O, McCloskey E (2009) BMD, clinical risk factors and their combination for hip fracture prevention. Osteoporos Int 20:1675-1682
18. Kanis JA, Oden A, Johnell O et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033-1046
19. Looker AC, Wahner HW, Dunn WL et al (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468-489
20. Population Division of the Department of Economic and Social Affairs of the United Nations. World Population Prospects: The 2008 Revision. http://esa.un.org/unpp
21. Orimo H, Sugioka Y, Fukunaga M et al (1998) Diagnostic criteria of primary osteoporosis. J Bone Miner Metab 16:139-150
22. Orimo H, Hayashi Y, Fukunaga M et al (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331-337
23. Hagino H, Katagiri H, Okano T, Yamamoto K, Teshima R (2005) Increasing incidence of hip fracture in Tottori Prefecture, Japan: trend from 1986 to 2001. Osteoporos Int 16:1963-1968
24. Hagino H, Furukawa K, Fujiwara S, Okano T, Katagiri H, Yamamoto K et al (2009) Recent trends in the incidence and lifetime risk of hip fracture in Tottori, Japan. Osteoporos Int 20:543-548
25. Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, Melton LJ, Cummings SR, Kanis JA, IOF CSA Working Group on Fracture Epidemiology (2011) Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 22:1277-1288
26. Kanis JA, McCloskey E, Johansson H, Odén A, Leslie WD (2012) FRAX® with and without BMD. Calcif Tissue Int 90:1-13
27. Kanis JA, Johansson H, Odén A et al (2009) Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX. Bone (NY) 44:1049-1054
28. McCloskey EV, Johansson H, Odén A et al (2009) Ten-year fracture probability identifies women who will benefit from clodronate therapy - additional results from a double blind, placebo controlled randomised study. Osteoporos Int 20:811-818
29. ®. J Bone Miner Res. doi: 10.1002/jbmr.1606
30. ®. Osteoporos Int 22:2347-2355
31. Kanis JA, Johansson H, Odén A et al (2010) A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRAX. Bone (NY) 47:729-735